In addition, of note, FGF21 has been shown to protect cardiomyopathy by inflammatory pathway [65], oxidative stress [66], AMP-activated protein kinase pathway [67] and lipid-lowering effect [68]. The gene discussed is FGF21; the disease is cardiomyopathy.